TY - JOUR AU - Charbel, H. AU - Al-Kawas, F. H. PY - 2011 DA - 2011// TI - Cholangiocarcinoma: epidemiology, risk factors, pathogenesis, and diagnosis JO - Current gastroenterology reports VL - 13 UR - https://doi.org/10.1007/s11894-011-0178-8 DO - 10.1007/s11894-011-0178-8 ID - Charbel2011 ER - TY - JOUR AU - Zhang, H. AU - Yang, T. AU - Wu, M. AU - Shen, F. PY - 2016 DA - 2016// TI - Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management JO - Cancer Lett VL - 379 UR - https://doi.org/10.1016/j.canlet.2015.09.008 DO - 10.1016/j.canlet.2015.09.008 ID - Zhang2016 ER - TY - STD TI - Chong DQ, Zhu AX. The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets. Oncotarget. 2016; ID - ref3 ER - TY - JOUR AU - Zhu, A. X. PY - 2015 DA - 2015// TI - Future directions in the treatment of cholangiocarcinoma. Best practice & research JO - Clinical gastroenterology VL - 29 ID - Zhu2015 ER - TY - STD TI - Vaquero J, Guedj N, Claperon A, Ho-Bouldoires TH, Paradis V and Fouassier L. Epithelial-mesenchymal transition in cholangiocarcinoma: from clinical evidence to regulatory networks. Journal of hepatology. 2016. ID - ref5 ER - TY - JOUR AU - Nieto, M. A. AU - Cano, A. PY - 2012 DA - 2012// TI - The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity JO - Semin Cancer Biol VL - 22 UR - https://doi.org/10.1016/j.semcancer.2012.05.003 DO - 10.1016/j.semcancer.2012.05.003 ID - Nieto2012 ER - TY - JOUR AU - Mitra, A. AU - Mishra, L. AU - Li, S. PY - 2015 DA - 2015// TI - EMT, CTCs and CSCs in tumor relapse and drug-resistance JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.4037 DO - 10.18632/oncotarget.4037 ID - Mitra2015 ER - TY - JOUR AU - Saito, R. A. AU - Watabe, T. AU - Horiguchi, K. AU - Kohyama, T. AU - Saitoh, M. AU - Nagase, T. PY - 2009 DA - 2009// TI - Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-08-3490 DO - 10.1158/0008-5472.CAN-08-3490 ID - Saito2009 ER - TY - JOUR AU - Diepenbruck, M. AU - Christofori, G. PY - 2016 DA - 2016// TI - Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe? JO - Curr Opin Cell Biol VL - 43 UR - https://doi.org/10.1016/j.ceb.2016.06.002 DO - 10.1016/j.ceb.2016.06.002 ID - Diepenbruck2016 ER - TY - JOUR AU - Qiao, P. AU - Li, G. AU - Bi, W. AU - Yang, L. AU - Yao, L. AU - Wu, D. PY - 2015 DA - 2015// TI - microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway JO - BMC Cancer VL - 15 UR - https://doi.org/10.1186/s12885-015-1359-x DO - 10.1186/s12885-015-1359-x ID - Qiao2015 ER - TY - JOUR AU - Krol, J. AU - Loedige, I. AU - Filipowicz, W. PY - 2010 DA - 2010// TI - The widespread regulation of microRNA biogenesis, function and decay JO - Nat Rev Genet VL - 11 ID - Krol2010 ER - TY - JOUR AU - Liang, D. AU - Xiao-Feng, H. AU - Guan-Jun, D. AU - Er-Ling, H. AU - Sheng, C. AU - Ting-Ting, W. PY - 1852 DA - 1852// TI - Activated STING enhances Tregs infiltration in the HPV-related carcinogenesis of tongue squamous cells via the c-jun/CCL22 signal JO - Biochim Biophys Acta VL - 2015 ID - Liang1852 ER - TY - JOUR AU - Park, S. M. AU - Gaur, A. B. AU - Lengyel, E. AU - Peter, M. E. PY - 2008 DA - 2008// TI - The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 JO - Genes Dev VL - 22 UR - https://doi.org/10.1101/gad.1640608 DO - 10.1101/gad.1640608 ID - Park2008 ER - TY - JOUR AU - Koutsaki, M. AU - Spandidos, D. A. AU - Zaravinos, A. PY - 2014 DA - 2014// TI - Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics JO - Cancer Lett VL - 351 UR - https://doi.org/10.1016/j.canlet.2014.05.022 DO - 10.1016/j.canlet.2014.05.022 ID - Koutsaki2014 ER - TY - JOUR AU - Chatterjee, R. AU - Mitra, A. PY - 2015 DA - 2015// TI - An overview of effective therapies and recent advances in biomarkers for chronic liver diseases and associated liver cancer JO - Int Immunopharmacol VL - 24 UR - https://doi.org/10.1016/j.intimp.2014.12.024 DO - 10.1016/j.intimp.2014.12.024 ID - Chatterjee2015 ER - TY - JOUR AU - Gregory, P. A. AU - Bracken, C. P. AU - Smith, E. AU - Bert, A. G. AU - Wright, J. A. AU - Roslan, S. PY - 2011 DA - 2011// TI - An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition JO - Mol Biol Cell VL - 22 UR - https://doi.org/10.1091/mbc.E11-02-0103 DO - 10.1091/mbc.E11-02-0103 ID - Gregory2011 ER - TY - JOUR AU - Zhang, H. F. AU - Alshareef, A. AU - Wu, C. AU - Li, S. AU - Jiao, J. W. AU - Cao, H. H. PY - 2015 DA - 2015// TI - Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin beta1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.5027 DO - 10.18632/oncotarget.5027 ID - Zhang2015 ER - TY - JOUR AU - Oishi, N. AU - Kumar, M. R. AU - Roessler, S. AU - Ji, J. AU - Forgues, M. AU - Budhu, A. PY - 2012 DA - 2012// TI - Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma JO - Hepatology VL - 56 UR - https://doi.org/10.1002/hep.25890 DO - 10.1002/hep.25890 ID - Oishi2012 ER - TY - JOUR AU - Xie, Y. AU - Wehrkamp, C. J. AU - Li, J. AU - Wang, Y. AU - Mott, J. L. AU - Oupicky, D. PY - 2016 DA - 2016// TI - Delivery of miR-200c Mimic with Poly(amido amine) CXCR4 Antagonists for Combined Inhibition of Cholangiocarcinoma Cell Invasiveness JO - Mol Pharm VL - 13 UR - https://doi.org/10.1021/acs.molpharmaceut.5b00894 DO - 10.1021/acs.molpharmaceut.5b00894 ID - Xie2016 ER - TY - JOUR AU - Sato, Y. AU - Harada, K. AU - Itatsu, K. AU - Ikeda, H. AU - Kakuda, Y. AU - Shimomura, S. PY - 2010 DA - 2010// TI - Epithelial-mesenchymal transition induced by transforming growth factor-{beta}1/Snail activation aggravates invasive growth of cholangiocarcinoma JO - Am J Pathol VL - 177 UR - https://doi.org/10.2353/ajpath.2010.090747 DO - 10.2353/ajpath.2010.090747 ID - Sato2010 ER - TY - JOUR AU - Pellikainen, J. M. AU - Kosma, V. M. PY - 2007 DA - 2007// TI - Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini review JO - Int J Cancer VL - 120 UR - https://doi.org/10.1002/ijc.22648 DO - 10.1002/ijc.22648 ID - Pellikainen2007 ER - TY - JOUR AU - Wu, J. AU - Cui, H. AU - Zhu, Z. AU - Wang, L. PY - 2016 DA - 2016// TI - MicroRNA-200b-3p suppresses epithelial-mesenchymal transition and inhibits tumor growth of glioma through down-regulation of ERK5 JO - Biochem Biophys Res Commun VL - 478 UR - https://doi.org/10.1016/j.bbrc.2016.08.085 DO - 10.1016/j.bbrc.2016.08.085 ID - Wu2016 ER - TY - JOUR AU - Drew, B. A. AU - Burow, M. E. AU - Beckman, B. S. PY - 1825 DA - 1825// TI - MEK5/ERK5 pathway: the first fifteen years JO - Biochim Biophys Acta VL - 2012 ID - Drew1825 ER - TY - JOUR AU - Siemens, H. AU - Jackstadt, R. AU - Hunten, S. AU - Kaller, M. AU - Menssen, A. AU - Gotz, U. PY - 2011 DA - 2011// TI - miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions JO - Cell Cycle VL - 10 UR - https://doi.org/10.4161/cc.10.24.18552 DO - 10.4161/cc.10.24.18552 ID - Siemens2011 ER - TY - JOUR AU - Cowden Dahl, K. D. AU - Dahl, R. AU - Kruichak, J. N. AU - Hudson, L. G. PY - 2009 DA - 2009// TI - The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells JO - Neoplasia VL - 11 UR - https://doi.org/10.1593/neo.09942 DO - 10.1593/neo.09942 ID - Cowden Dahl2009 ER - TY - JOUR AU - Su, W. AU - Xia, J. AU - Chen, X. AU - Xu, M. AU - Nie, L. AU - Chen, N. PY - 2014 DA - 2014// TI - Ectopic expression of AP-2alpha transcription factor suppresses glioma progression JO - Int J Clin Exp Pathol VL - 7 ID - Su2014 ER - TY - JOUR AU - Campillos, M. AU - Garcia, M. A. AU - Valdivieso, F. AU - Vazquez, J. PY - 2003 DA - 2003// TI - Transcriptional activation by AP-2alpha is modulated by the oncogene DEK JO - Nucleic Acids Res VL - 31 UR - https://doi.org/10.1093/nar/gkg247 DO - 10.1093/nar/gkg247 ID - Campillos2003 ER - TY - JOUR AU - Zhang, Z. AU - Zhang, L. AU - Jia, L. AU - Cui, S. AU - Shi, Y. AU - Chang, A. PY - 2013 DA - 2013// TI - AP-2alpha suppresses invasion in BeWo cells by repression of matrix metalloproteinase-2 and -9 and up-regulation of E-cadherin JO - Mol Cell Biochem VL - 381 UR - https://doi.org/10.1007/s11010-013-1685-8 DO - 10.1007/s11010-013-1685-8 ID - Zhang2013 ER - TY - JOUR AU - Kim, S. AU - Lim, J. H. AU - Woo, C. H. PY - 2013 DA - 2013// TI - ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation JO - Am J Pathol VL - 183 UR - https://doi.org/10.1016/j.ajpath.2013.08.014 DO - 10.1016/j.ajpath.2013.08.014 ID - Kim2013 ER - TY - JOUR AU - Pan, Y. AU - Liang, H. AU - Chen, W. AU - Zhang, H. AU - Wang, N. AU - Wang, F. PY - 2015 DA - 2015// TI - microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs JO - RNA Biol VL - 12 UR - https://doi.org/10.1080/15476286.2015.1017208 DO - 10.1080/15476286.2015.1017208 ID - Pan2015 ER - TY - JOUR AU - Ning, X. AU - Shi, Z. AU - Liu, X. AU - Zhang, A. AU - Han, L. AU - Jiang, K. PY - 2015 DA - 2015// TI - DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression JO - Cancer Lett VL - 359 UR - https://doi.org/10.1016/j.canlet.2015.01.005 DO - 10.1016/j.canlet.2015.01.005 ID - Ning2015 ER -